102 related articles for article (PubMed ID: 1563533)
21. [Principles of immunotherapy in insulin-dependent diabetes mellitus].
Bretzel RG
Wien Klin Wochenschr; 1988 Jun; 100(13):435-42. PubMed ID: 3043913
[TBL] [Abstract][Full Text] [Related]
22. New prospects for immunotherapy at diagnosis of type 1 diabetes.
Pozzilli P; Leslie RD
Diabetes Metab Res Rev; 2009 May; 25(4):299-301. PubMed ID: 19405079
[TBL] [Abstract][Full Text] [Related]
23. Expanding immuno-therapies for type 1 diabetes.
Diabetes Obes Metab; 2000 Apr; 2(2):118. PubMed ID: 11220525
[No Abstract] [Full Text] [Related]
24. [Present status of therapeutics in diabetology].
Leutenegger M; Grandmottet P
Therapie; 1989; 44(4):239-43. PubMed ID: 2688183
[No Abstract] [Full Text] [Related]
25. [Type I diabetes mellitus: immunopathogenesis and chances of primary immunotherapy].
Ziegler AG; Standl E
Med Klin (Munich); 1987 Oct; 82(22):796-800. PubMed ID: 3316970
[No Abstract] [Full Text] [Related]
26. Early intervention in insulin-dependent diabetes mellitus.
Cahill GF
Curr Probl Clin Biochem; 1983; 12():108-18. PubMed ID: 6418442
[No Abstract] [Full Text] [Related]
27. [Immunotherapeutic management of juvenile diabetes mellitus].
Moncada E
Rev Esp Fisiol; 1989; 45 Suppl():301-8. PubMed ID: 2701766
[TBL] [Abstract][Full Text] [Related]
28. Advances in Type 1 diabetes therapeutics: immunomodulation and beta-cell salvage.
Waldron-Lynch F; Herold KC
Endocrinol Metab Clin North Am; 2009 Jun; 38(2):303-17, viii. PubMed ID: 19328413
[TBL] [Abstract][Full Text] [Related]
29. Editorial Comment on type 1 diabetes and antigen-specific immunotherapy.
Lernmark Å; Larsson HE
J Intern Med; 2011 Aug; 270(2):132-5. PubMed ID: 21668820
[No Abstract] [Full Text] [Related]
30. Dendritic cell mediated therapy for immunoregulation of type 1 diabetes mellitus.
Phillips BE; Giannoukakis N; Trucco M
Pediatr Endocrinol Rev; 2008 Jun; 5(4):873-9. PubMed ID: 18552749
[TBL] [Abstract][Full Text] [Related]
31. Type 1 diabetes: how to resist a fatal attraction.
Roep BO
Neth J Med; 2002 Aug; 60(7):296-7. PubMed ID: 12430578
[No Abstract] [Full Text] [Related]
32. Immunotherapy for the prevention and treatment of type 1 diabetes.
Goudy KS; Tisch R
Int Rev Immunol; 2005; 24(5-6):307-26. PubMed ID: 16318984
[TBL] [Abstract][Full Text] [Related]
33. Immunologic "vaccination" for the prevention of autoimmune diabetes (type 1A).
Simone EA; Wegmann DR; Eisenbarth GS
Diabetes Care; 1999 Mar; 22 Suppl 2():B7-15. PubMed ID: 10097893
[TBL] [Abstract][Full Text] [Related]
34. [Immunogenetics and new therapies in type I diabetes mellitus].
Gannage-Yared MH
J Med Liban; 1999; 47(2):139-43. PubMed ID: 10410471
[No Abstract] [Full Text] [Related]
35. White cells transfusion in recent onset type 1 diabetes.
Pozzilli P; Ghirlanda G; Manna R; Alfano G; Greco AV; Andreani D
Diabetes Res; 1986 Jun; 3(5):273-6. PubMed ID: 2943548
[TBL] [Abstract][Full Text] [Related]
36. Achieving antigen-specific tolerance in diabetes: regulating specifically.
Chen W; Bluestone JA; Herold KC
Int Rev Immunol; 2005; 24(5-6):287-305. PubMed ID: 16318983
[TBL] [Abstract][Full Text] [Related]
37. Reversal of type 1 diabetes in mice.
Faustman DL
N Engl J Med; 2007 Jan; 356(3):311-2. PubMed ID: 17229964
[No Abstract] [Full Text] [Related]
38. [Immunopathogenesis and immunotherapy of type I diabetes mellitus].
Kuraeva TL
Probl Endokrinol (Mosk); 1991; 37(1):63-7. PubMed ID: 2027876
[No Abstract] [Full Text] [Related]
39. Immunotherapy of type I diabetes.
Kolb H; Greulich B; Kiessel U; Gries FA
Lancet; 1982 Jul; 2(8289):97-8. PubMed ID: 6123832
[No Abstract] [Full Text] [Related]
40. Preventing type 1 diabetes may someday become possible.
Vastag B
JAMA; 2002 Feb; 287(6):701-2. PubMed ID: 11851514
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]